ME 3221
Latest Information Update: 29 Nov 2006
At a glance
- Originator Meiji Seika Kaisha
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension